Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Pediatric heart failure from myocarditis or MIS-C is managed by identifying immune triggers, using multimodal tests to distinguish active inflammation from chronic damage, and…
Continuous heart rate monitoring helps detect early signs of illness in premature infants with necrotizing enterocolitis, allowing for timely intervention that can improve…
Yes, early surgery significantly reduces long-term death risk in asymptomatic very severe aortic stenosis, with a 90% lower risk of cardiovascular death over 10 years.
Yes, multiple large studies show that RAS inhibitors after TAVR are associated with lower all-cause and cardiovascular mortality.
Yes, sex may influence cardiovascular death risk after TIA, but evidence is mixed; some studies show no significant difference, while others suggest women may have lower risk.
Yes, machine-learning models can predict coronary artery lesions in children with Kawasaki disease, with some achieving high accuracy (AUC up to 0.95).
No, adding prednisolone to standard treatment did not significantly reduce coronary artery lesions at 1 month in newly diagnosed Kawasaki disease patients, according to a large…
Routine lab indicators like C-reactive protein and erythrocyte sedimentation rate help predict coronary artery lesions in children with Kawasaki disease.
Erythropoiesis-stimulating agents (ESAs) reduce total heart failure hospitalizations and improve exercise tolerance in adults with chronic heart failure and anaemia, but do not…
Yes, Xarelto (rivaroxaban) is FDA-approved to reduce stroke risk in nonvalvular atrial fibrillation and to treat deep vein thrombosis, making it effective for patients with both…
Yes, the apical sparing ratio (ASR) can help detect cardiac amyloidosis, but it is not perfect—it has moderate accuracy and should be used alongside other tests.
Cardiac MRI with contrast and bone scintigraphy are the best tests for distinguishing cardiac amyloidosis from other heart issues, with echocardiography as a useful first…
A 2024 trial found that adding Qishen Yiqi dropping pills to standard Western medicine improved clinical effectiveness and heart function in chronic heart failure patients.
Coping experiences for CHF patients and caregivers center on differing views of illness, emotional exhaustion, strained relationships, and a need for support to find new meaning.
No, alternative loop diuretics (torsemide, azosemide, piretanide) do not reduce hospitalizations compared to furosemide in chronic heart failure, based on a systematic review of…
A combination of echocardiography, cardiac magnetic resonance, and myocardial perfusion imaging provides the highest accuracy for detecting heart injury in heat stroke patients.
Current evidence does not show a clear link between metabolic syndrome and higher restenosis risk after PCI, though related factors like insulin resistance may play a role.
A nerve block (PIFB) alone did not significantly reduce overall chronic pain after off-pump CABG, but it helped with acute pain and reduced moderate-to-severe chronic pain.
Yes, high GDF-15 levels in the blood are strongly linked to a higher risk of death in acute heart failure patients, with a meta-analysis showing nearly three times the risk.
Yes, heart disease was the second leading cause of death in the US in 2021, ranking behind only COVID-19.
Sepsis-induced cardiomyopathy is caused by inflammation, mitochondrial damage, and calcium handling problems. New treatments include repurposed drugs, traditional Chinese…
There is no confirmed safety data for ifetroban in boys with Duchenne muscular dystrophy and cardiomyopathy because the relevant Phase 2 trial has not yet published safety results.
Yes, LGE-CMR positivity is linked to a higher risk of sudden cardiac death in cardiomyopathy patients, especially those with non-ischemic cardiomyopathy.
Adults with sickle cell disease show three main echocardiographic profiles: high cardiac output with enlarged chambers, mild remodeling with higher pulmonary pressure, or…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.